long-term follow-up of hematopoiesis after irradiation prevents nonhuman primates from myelosuppression: growth and development factor, and interleukin-3 in combination soon Single administration of stem cell factor, FLT-3 ligand, megakaryocyte

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• The medical basis for radiation-accident preparedness

  2013cited by this paper
• Non-targeted and Delayed Effects of Exposure to Ionizing Radiation: I. Radiation-Induced Genomic Instability and Bystander Effects In Vitro

  2012cited by this paper
• Modulation of intercellular communication mediated at the cell surface and on extracellular, plasma membrane-derived vesicles by ionizing radiation.

  2003cited by this paper
• Short-term injection of antiapoptotic cytokine combinations soon after lethal gamma -irradiation promotes survival.

  2003cited by this paper
• Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor.

  2002cited by this paper
• Hematologic consequences of exposure to ionizing radiation.

  2002cited by this paper
• Effects of the Combination of Thrombopoietin with Cytokines on the Survival of X-Irradiated CD34+ Megakaryocytic Progenitor Cells from Normal Human Peripheral Blood

  2002cited by this paper
• Mobilized bone marrow cells repair the infarcted heart, improving function and survival

  2001cited by this paper
• Thrombopoietin therapy increases platelet yields in healthy platelet donors.

  2001cited by this paper
• Mpl ligand prevents lethal myelosuppression by inhibiting p53-dependent apoptosis.

  2001cited by this paper
• Thrombocytopenia caused by the development of antibodies to thrombopoietin.

  2001cited by this paper
• Promegapoietin‐1a, an Engineered Chimeric IL‐3 and Mpl‐L Receptor Agonist, Stimulates Hematopoietic Recovery in Conventional and Abbreviated Schedules Following Radiation‐Induced Myelosuppression in Nonhuman Primates

  2001cited by this paper
• Single administration of thrombopoietin to lethally irradiated mice prevents infectious and thrombotic events leading to mortality.

  2001cited by this paper
• The effect of granulocyte-macrophage colony-stimulating factor (GM-CSF) on primitive hematopoietic stem cell (PHSC) function and numbers, after chemotherapy.

  2001cited by this paper
• Irradiation enhances the support of haemopoietic cell transmigration, proliferation and differentiation by endothelial cells

  2001cited by this paper
• Granulocyte‐Colony Stimulating Factor Impedes Recovery from Damage Caused by Cytotoxic Agents through Increased Differentiation at the Expense of Self‐Renewal

  2000cited by this paper
• The Reduction of In Vitro Radiation‐Induced Fas‐Related Apoptosis in CD34+ Progenitor Cells by SCF, FLT‐3 Ligand, TPO, and IL‐3 in Combination Resulted in CD34+ Cell Proliferation and Differentiation

  1999cited by this paper
• The prolonged hematologic effects of a single injection of PEG-rHuMGDF in normal and thrombocytopenic mice.

  1999cited by this paper
• Immunogenicity of Thrombopoietin Mimetic Peptide GW395058 in BALB/c Mice and New Zealand White Rabbits: Evaluation of the Potential for Thrombopoietin Neutralizing Antibody Production in Man

  1999cited by this paper
• Dosimetry for total body irradiation of rhesus monkeys with 300 kV X-rays.

  1998cited by this paper
• In vivo expansion of hemopoietic stem cells

  1998cited by this paper
• A single dose of thrombopoietin shortly after myelosuppressive total body irradiation prevents pancytopenia in mice by promoting short-term multilineage spleen-repopulating cells at the transient expense of bone marrow-repopulating cells.

  1998cited by this paper
• Multilineage hematopoietic recovery by a single injection of pegylated recombinant human megakaryocyte growth and development factor in myelosuppressed mice.

  1998cited by this paper
• Granulocyte colony-stimulating factor enhances bone marrow stem cell damage caused by repeated administration of cytotoxic agents.

  1998cited by this paper
• The Efficacy of Single-Dose Administration of Thrombopoietin With Coadministration of Either Granulocyte/Macrophage or Granulocyte Colony-Stimulating Factor in Myelosuppressed Rhesus Monkeys

  1997cited by this paper
• Ability of early acting cytokines to directly promote survival and suppress apoptosis of human primitive CD34+CD38- bone marrow cells with multilineage potential at the single-cell level: key role of thrombopoietin.

  1997cited by this paper
• The efficacy of single-dose administration of thrombopoietin with coadministration of either granulocyte/macrophage or granulocyte colony-stimulating factor in myelosuppressed rhesus monkeys.

  1997cited by this paper
• Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species

  1997cited by this paper
• Simultaneous administration of TPO and G-CSF after cytoreductive treatment of rhesus monkeys prevents thrombocytopenia, accelerates platelet and red cell reconstitution, alleviates neutropenia, and promotes the recovery of immature bone marrow cells.

  1997cited by this paper
• Acute radiation disease and biological dosimetry in 1993

  1997cited by this paper
• Combined administration of recombinant human megakaryocyte growth and development factor and granulocyte colony-stimulating factor enhances multilineage hematopoietic reconstitution in nonhuman primates after radiation-induced marrow aplasia.

  1996cited by this paper
• Thrombopoietin expands erythroid, granulocyte-macrophage, and megakaryocytic progenitor cells in normal and myelosuppressed mice.

  1996cited by this paper
• Haematopoietic growth factors in the treatment of therapeutic and accidental irradiation-induced bone marrow aplasia.

  1995cited by this paper
• Recombinant human interleukin-11 stimulates multilineage hematopoietic recovery in mice after a myelosuppressive regimen of sublethal irradiation and carboplatin.

  1994cited by this paper
• Combination protocols of cytokine therapy with interleukin-3 and granulocyte-macrophage colony-stimulating factor in a primate model of radiation-induced marrow aplasia.

  1993cited by this paper
• Recombinant glycosylated human interleukin-6 accelerates peripheral blood platelet count recovery in radiation-induced bone marrow depression in baboons.

  1992cited by this paper
• Use of hematopoietic growth factors in radiation accidents.

  1990cited by this paper
• The Efficient Design of Transplantable Tumour Assays

  1963cited by this paper
• Criticality accidents in Vinca, Yugoslavia, and Oak Ridge, Tennessee. Comparison of radiation injuries and results of therapy.

  1962cited by this paper

• Role of thrombocytopenia in radiation-induced mortality and review of therapeutic approaches targeting platelet regeneration after radiation exposure

  2016cites this paper